Work

1717TiP CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma

Year: 2024

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.2128

Authors: L. Albiges, C. Suarez Rodriguez, G. Procopio, A. Bex, V. Gruenwald, M. Schmidinger, B. Melichar, G.A. De Velasco Oria, C.D. Bergerot, R. Giles, R. Woodward, A.R. Ferreira, N. Rioux-Leclercq, J. Bonastre, M. Claveau, R. Flippot, B. Escudier, S. Foulon, T.B. Powles

Institutions: Institut Gustave Roussy, Vall d'Hebron Hospital Universitari, Fondazione IRCCS Istituto Nazionale dei Tumori, Royal Free London NHS Foundation Trust, Essen University Hospital, Vienna General Hospital, Medical University of Vienna, University Hospital Olomouc, Hospital Universitario 12 De Octubre, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Fondation Gustave Roussy, St Bartholomew's Hospital, Barts Health NHS Trust

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Institut Gustave-Roussy, Fondation Gustave Roussy, CRIS Cancer Foundation

OpenAlex ID: W4402558677

FWCI: 2.033

Cites:

Cited by: 7

Related to: 10